申请人:Recurium IP Holdings, LLC
公开号:US20220024939A1
公开(公告)日:2022-01-27
Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as breast cancer.